NCT00292461View on ClinicalTrials.gov

A Study for Evaluating the Efficacy and Safety of Zonisamide and Lamotrigine (Lamictal) for Subjects With Refractory Simple Partial, Complex Partial or Partial With Secondary Generalized Seizures

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

August 31, 2009

Study Completion Date

September 30, 2009

Conditions

Epilepsy

Interventions

DRUG

Zonisamide

Tablet once or twice daily orally for 16 weeks

DRUG

Lamotrigine

Tablet once daily orally for 16 weeks

Trial Locations (8)

Unknown

Changhua Christian Hospital, Changhua

Chang-Gung Memorial Hospital (CGMH), Kaohsiung

Chang-Gung Memorial Hospital (CGMH), Linkou

China Medical University Hospital (CMUH), Taichun

National Cheng Kung University Hospital, Tainan

Chang-Gung Memorial Hospital (CGMH), Taipei

Taipei Tzu Chi General Hospital, Taipei

Taipei Veterans General Hospital, Taipei

All Listed Sponsors

lead

Eisai Inc.

INDUSTRY

NCT00292461 - A Study for Evaluating the Efficacy and Safety of Zonisamide and Lamotrigine (Lamictal) for Subjects With Refractory Simple Partial, Complex Partial or Partial With Secondary Generalized Seizures | Biotech Hunter | Biotech Hunter